Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...
Recently, an international commission proposed a revised definition of obesity that focuses on how excess body fat affects the body, and factors in waist circumference, rather than simply ...
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...
The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...
Over the past decades, obesity has reached epidemic proportions, now affecting more than 1 billion people worldwide.
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...